Ameriprise
PIII icon

Ameriprise’s P3 Health Partners PIII Stock Holding History

Ameriprise’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-126,562
Closed -$2.85M – 3988
2024
Q2 		$2.85M Sell
126,562
-23,771
-16% -$710K ﹤0.01% 2696
2024
Q1 		$7.74M Buy
150,333
+41,503
+38% +$2.31M ﹤0.01% 2019
2023
Q4 		$7.67M Buy
108,830
+33
+0% +$2.28K ﹤0.01% 2010
2023
Q3 		$8M Buy
108,797
+56,632
+109% +$5.88M ﹤0.01% 1886
2023
Q2 		$7.8M Sell
52,165
-10,787
-17% -$1.49M ﹤0.01% 2000
2023
Q1 		$3.34M Buy
62,952
+11
+0% +$661 ﹤0.01% 2579
2022
Q4 		$5.79M Buy
62,941
+223
+0.4% +$48.3K ﹤0.01% 2186
2022
Q3 		$14.5M Buy
62,718
+686
+1% +$172K 0.01% 1397
2022
Q2 		$11.5M Sell
62,032
-21,985
-26% -$6.13M ﹤0.01% 1626
2022
Q1 		$32.9M Buy
84,017
+4,344
+5% +$1.3M 0.01% 1006
2021
Q4 		$27M Buy
+79,673
New +$38M 0.01% 1195

Other funds holding PIII

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $78.6B AUM 28.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise's PIII Position: Q3 2024 in Review

Ameriprise sold out of P3 Health Partners (PIII) in Q3 2024, closing a stake of 126,562 shares — an estimated $2.85M sold.

Ameriprise first reported a position in PIII in Q4 2021 and held it in 11 quarters. The position peaked at $32.9M in Q1 2022. 46 funds tracked by Wall St. Rank hold PIII as of Q3 2024.

  • Ameriprise reported no remaining P3 Health Partners position as of Q3 2024 after selling out during the quarter.
  • Ameriprise sold 126,562 P3 Health Partners shares in Q3 2024, an estimated $2.85M.
  • Ameriprise first reported a position in P3 Health Partners in Q4 2021 and held it in 11 quarters.
  • Ameriprise's P3 Health Partners position peaked at $32.9M in Q1 2022.
  • 46 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2024.

Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.